Showing 1,392 results

Filters Content type: Editors' picks Country: South Africa
Starting treatment

TAC welcomes the inclusion of fixed-dose combination medicines in the 2013- 2014 antiretroviral medicines tender

Editor's pick
TAC
30 November 2012
Access to healthcare

SOUTH AFRICA: New ARV tender drops prices, changes treatment

Editor's pick
IRIN Plus News
30 November 2012
Finance & funding

South Africa: Country Saves R2.2 Billion in HIV Drug Tender

Editor's pick
AllAfrica
30 November 2012
Starting treatment

South Africa: HIV Patients to Take One ARV Tablet Daily

Editor's pick
AllAfrica
30 November 2012
Pharmaceutical industry

South Africa awards $667 million HIV drugs supply contract

Editor's pick
Reuters
29 November 2012
Government, leadership & policy

South Africa: Section27 chides UNAIDS’ upbeat report on HIV

Editor's pick
Business Day
28 November 2012
Violence

South Africa: No Stop to HIV Infections Unless Gender Violence Addressed

Editor's pick
AllAfrica
27 November 2012
Epidemiology

South Africa: Government Responds to the 2012 UNAIDS Report

Editor's pick
AllAfrica
22 November 2012
Access to healthcare

South Africa: Nation Increases HIV Treatment By 75 Percent

Editor's pick
AllAfrica
22 November 2012
TB diagnosis

Xpert test for TB could help prevent deaths in southern Africa, but at substantial cost

Editor's pick
Eurekalert Inf Dis
21 November 2012
Epidemiology & behaviour

UNAIDS reports a more than 50% drop in new HIV infections across 25 countries

Editor's pick
UNAIDS
20 November 2012
Drug-resistant TB

MSF: Implementation of new test increases drug-resistant TB diagnosis while shortening treatment initiation time

Editor's pick
Médecins Sans Frontières press release
15 November 2012
New & experimental hepatitis C treatment

Bristol-Myers Squibb’s Investigational Hepatitis C Compounds Lambda and Daclatasvir Plus Ribavirin Achieved SVR12 in 93% of Genotype 1b Treatment-Naive Patients In Phase IIb Study

Editor's pick
HCV New Drugs Research
14 November 2012
New & experimental hepatitis C treatment

Gilead May Top Rivals With Hepatitis C Therapy Results

Editor's pick
Bloomberg BusinessWeek
14 November 2012
New & experimental hepatitis C treatment

Abbott Announces Phase 3 Interferon-free Hepatitis C Regimens to be Studied in Broad Patient Populations

Editor's pick
Abbott press release
14 November 2012
Pregnancy and vertical transmission

South Africa: Challenges of Breast-Feeding

Editor's pick
AllAfrica
13 November 2012
Hepatitis C symptoms & diagnosis

Background liver proliferation linked to noncirrhotic HCC in patients with HCV

Editor's pick
Healio Hepatology
13 November 2012
New & experimental hepatitis C treatment

Achillion Provides Update on Clinical HCV Development Programs

Editor's pick
Achillion press release
13 November 2012
New & experimental hepatitis C treatment

Novartis' Certican succeeds in liver transplant trial

Editor's pick
Reuters
12 November 2012
New & experimental hepatitis C treatment

AASLD-GI-5005 Improves Virologic Clearance of HCV in Combination with PegIFN/Ribavirin in IL28B T/T Patients

Editor's pick
HCV New Drugs Research
12 November 2012
New & experimental hepatitis C treatment

Gilead, Abbott Unwrap Dueling Hep C Pill Data

Editor's pick
The Street
12 November 2012
New & experimental hepatitis C treatment

ALS-2200 (VX-135), Vertex's Oral Nucleotide Analogue in Development for Hepatitis C

Editor's pick
Vertex press release
11 November 2012
Cancer

The connection between Fatty Liver Disease and the Increase in the Rate of Liver Cancer

Editor's pick
AASLD press release
11 November 2012
New & experimental hepatitis C treatment

Twice-Daily Telaprevir Achieved Viral Cure (SVR12) Rates Similar to Those Treated Three Times Daily

Editor's pick
Vertex press release
11 November 2012